Valuation (66%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -37.14 | 16.26 |
| PEG Ratio (TTM) | -2.93 | 1.57 |
| P/S Ratio (TTM) | 2.30 | 2.62 |
| P/B Ratio (TTM) | 0.88 | 1.90 |
| P/FCF Ratio (TTM) | 3.71 | 11.27 |
| Price to 5YR AVG Earnings Ratio | 13.43 | 14.29 |
| Price to 5YR AVG FCF Ratio | 6.12 | 8.15 |
Profitability (5%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -0.30% | 1,525.79% |
| ROE (TTM) | -2.50% | 8.86% |
| Net Profit Margin (TTM) | -6.16% | 15.64% |
| ROIC 5YR AVG | 6.11% | 20.60% |
Growth (63%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -104.78% | 7.96% | -19.12% |
| Revenue | 136.37% | 30.87% | 27.73% |
| Net Income | -93.45% | 29.32% | -6.45% |
| Cash Flow | 43.03% | 110.12% | 68.31% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.38 | 3.16 |
| Quick Ratio (TTM) | 0.38 | 4.79 |
| D/E Ratio (TTM) | 0.88 | 1.26 |
| Interest Coverage (TTM) | 0.03 | 0.63 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | 0.03 | 0.38 |
| LTL to 5YR AVG FCF | 4.13 | 6.30 |
| Shares Outstanding Growth 5YR AVG | 13.79% | 4.79% |